By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DelMar Pharmaceuticals 

999 West Broadway
Suite 720
  British Columbia  V5Z 1K5  Canada
Phone: 1-604-629-5989 Fax:



Company News
DelMar Pharmaceuticals Release: VAL-083 Demonstrates Promise As A Potential Treatment For Non-Small Cell Lung Cancer 10/9/2014 9:12:45 AM
DelMar Pharmaceuticals Announces Presentations At Upcoming Scientific Meetings 10/6/2014 11:15:53 AM
DelMar Pharmaceuticals To Present At The SeeThruEquity Fall Microcap Investor Conference 9/8/2014 7:46:46 AM
DelMar Pharmaceuticals Receives Notice Of Allowance For Second U.S. Patent For VAL-083 9/3/2014 11:28:13 AM
DelMar Pharmaceuticals Fiscal 2014 Year End Results And Summary Of Recent Developments 8/29/2014 11:11:59 AM
DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 8/28/2014 1:24:36 PM
DelMar Pharmaceuticals Provides Update On Glioblastoma Clinical Trial And Results Of Warrant Tender Offer 8/19/2014 7:45:29 AM
DelMar Pharmaceuticals Announces Change Of Fiscal Year End And Provides Update On Glioblastoma Clinical Trial 7/25/2014 8:42:51 AM
DelMar Pharmaceuticals Receives Funding From The Canadian Federal Government 7/9/2014 9:37:08 AM
DelMar Pharmaceuticals To Webcast, Live, At June 5th 6/3/2014 6:33:06 AM